Indefinite Delivery Contract 75D30122D15427

Award Date 9/20/22
Last Date to Order 9/19/27
Federal Agency
CDC Pittsburgh
Federal Contract Vehicle
Pricing Type
Cost No Fee
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is for the Vaccine Safety Datalink (VSD) program, which is managed by the Centers for Disease Control and Prevention (CDC). The prime contractor is Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a large non-profit healthcare provider and research organization. The VSD program supports ongoing epidemiological and clinical research to evaluate vaccine safety through collaboration with integrated healthcare delivery organizations like Kaiser...
The federal contract IDV award is for the Vaccine Safety Datalink (VSD) program, a collaborative project between the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) and several healthcare organizations. The prime contractor is Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. This is a multiple award Indefinite Delivery Contract (IDC) with a $149 million ceiling value and...
The Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, supports the Vaccine Safety Datalink (VSD) program. The VSD is an ongoing collaboration between the CDC and integrated healthcare organizations focused on monitoring vaccine safety. Under this $149 million IDC, Kaiser Permanente, a non-profit healthcare provider and research organization, will conduct epidemiological and...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract with a potential value of $149 million to Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. The contract supports the Vaccine Safety Datalink program, which monitors vaccine safety through collaborative studies using large linked databases. Under the contract, Kaiser Permanente will provide Vaccine Safety Datalink services to assist...
Kaiser Foundation Hospitals, operating as Kaiser Permanente, has been awarded a multiple award indefinite delivery contract by the Department of Health and Human Services Centers for Disease Control and Prevention. The 2023 Clinical Immunization Safety Assessment Base IDIQ has a potential value of $86M with a period of performance through September 2028. Under this contract, Kaiser Permanente will support the Centers for Disease Control and Prevention's immunization safety assessment...
The Centers for Disease Control and Prevention awarded an indefinite-delivery indefinite-quantity multiple award contract under the Vaccine Safety Datalink program. With a potential value of one hundred forty-nine million U.S. dollars and a period of performance through February 2027, this contract provides vaccine safety data linking services. Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, operating as Kaiser Permanente, received a five million eight hundred...
The federal contract IDV being summarized is the Accelerating Change and Transformation in Organizations and Networks IV (ACTION IV) IDIQ awarded to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ). This multiple award, indefinite delivery contract is valued up to $5,000,000 and runs through May 2025. It is intended to procure a variety of healthcare research, data analytics,...
The federal contract IDV is an Indefinite Delivery Contract awarded by the Social Security Administration (SSA), a civilian federal agency, to Ochin, Inc., a nonprofit organization specializing in health information technology services. The contract has a ceiling value of $284,156 and a period of performance through June 2012. The primary focus of the contract is to support the Centers for Disease Control and Prevention's (CDC) Vaccine Safety Datalink (VSD) project, which involves...
The federal contract IDV awarded to Denver Health and Hospital Authority (Denver Health) by the Centers for Disease Control and Prevention (CDC) is a $149 million multiple award Indefinite Delivery Contract (IDC) to provide Vaccine Safety Datalink (VSD) services. VSD is an ongoing program managed by the CDC to support vaccine safety monitoring and research. Under this IDC, Denver Health has received a $3,015,216.50 Delivery Order to provide VSD services. As a 555-bed academic health system and...
This single award IDV was transferred from the National Background Investigations Bureau to the Defense Counterintelligence and Security Agency on October 1, 2019. It has a potential value of $174,856 and period of performance through September 30, 2022 for ordering. The prime contractor is the Department of State Health Services, a U.S. state government entity that has provided various public health services to federal agencies through prior contracts and grants. Under this IDV, the...

The federal contract IDV award is for the Vaccine Safety Datalink (VSD) program, a long-standing initiative led by the Centers for Disease Control and Prevention (CDC) to conduct epidemiological studies and surveillance to evaluate vaccine safety. The prime contractor is Kaiser Foundation Hospitals, a non-profit healthcare provider and research organization that leverages its extensive patient data and research capabilities to support various public health initiatives for federal agencies like the CDC and NIH.

This $149 million multiple-award IDV contract does not have a set-aside designation, reflecting Kaiser Permanente's status as a major healthcare research entity. A $20.4 million delivery order was awarded to Kaiser Foundation Hospitals under this IDV, with a performance period ending in September 2027. Kaiser Permanente also holds IDV contracts with the CDC for the Clinical Immunization Safety Assessment (CISA) program and with the National Heart, Lung, and Blood Institute for the Coronary Artery Risk Development in Young Adults (CARDIA) study, demonstrating its long-term commitment to supporting federal public health and medical research initiatives.

Generated 9/7/24, 9:41 AM